NO20021251L - Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendbare som D4antagonister - Google Patents

Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendbare som D4antagonister

Info

Publication number
NO20021251L
NO20021251L NO20021251A NO20021251A NO20021251L NO 20021251 L NO20021251 L NO 20021251L NO 20021251 A NO20021251 A NO 20021251A NO 20021251 A NO20021251 A NO 20021251A NO 20021251 L NO20021251 L NO 20021251L
Authority
NO
Norway
Prior art keywords
thienylpyrrazolyl
antagonists
compounds
tienoisoxazolyl
substituted propyl
Prior art date
Application number
NO20021251A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021251D0 (no
Inventor
David M Fink
Brian Scott Freed
Nicholas Joseph Hrib
Jr Raymond Walter Kosley
George E Lee
Gregory Harold Merriman
Barbara Seavey Rauckman
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20021251D0 publication Critical patent/NO20021251D0/no
Publication of NO20021251L publication Critical patent/NO20021251L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20021251A 1999-09-14 2002-03-13 Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendbare som D4antagonister NO20021251L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39608199A 1999-09-14 1999-09-14
PCT/US2000/024962 WO2001019833A1 (fr) 1999-09-14 2000-09-13 Derives thienoisoxazolyle et thienylpyrrazolyle du propyle a substitution phenoxy, antagonistes du d¿4?

Publications (2)

Publication Number Publication Date
NO20021251D0 NO20021251D0 (no) 2002-03-13
NO20021251L true NO20021251L (no) 2002-05-10

Family

ID=23565772

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021251A NO20021251L (no) 1999-09-14 2002-03-13 Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendbare som D4antagonister

Country Status (26)

Country Link
EP (1) EP1216250B1 (fr)
JP (1) JP4847662B2 (fr)
KR (1) KR20020027647A (fr)
AR (1) AR032134A1 (fr)
AT (1) ATE254621T1 (fr)
AU (1) AU7577400A (fr)
BR (1) BR0014515A (fr)
CA (1) CA2383340C (fr)
CY (1) CY1101692T1 (fr)
CZ (1) CZ2002897A3 (fr)
DE (1) DE60006699T2 (fr)
DK (1) DK1216250T3 (fr)
EA (1) EA200200355A1 (fr)
EE (1) EE200200135A (fr)
ES (1) ES2209995T3 (fr)
HR (1) HRP20020220A2 (fr)
HU (1) HUP0203526A3 (fr)
IL (1) IL148623A0 (fr)
MX (1) MXPA02002695A (fr)
NO (1) NO20021251L (fr)
PL (1) PL354515A1 (fr)
PT (1) PT1216250E (fr)
SK (1) SK3512002A3 (fr)
TW (1) TW530060B (fr)
WO (1) WO2001019833A1 (fr)
ZA (1) ZA200201762B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
CA2438318A1 (fr) * 2001-02-16 2002-08-29 Aventis Pharmaceuticals Inc. Nouveaux derives heterocycliques d'amides et leur utilisation comme ligands du recepteur de la dopamine d3
WO2002083648A1 (fr) * 2001-04-16 2002-10-24 Eisai Co., Ltd. Nouveau compose a base de 1h-indazole
KR20040020457A (ko) * 2002-08-30 2004-03-09 주식회사 대웅 3-｛2-[4-(6-플루오로벤조[ｄ]이속사졸-3-일)피페리디노]에틸｝-2-메틸-6,7,8,9-테트라하이드로-4Ｈ-피리도[1,2-ａ]피리미딘-4-온 또는 그 산부가염의 제조방법
WO2004069818A1 (fr) * 2003-01-17 2004-08-19 Cv Therapeutics Inc. Composes heterocycliques substitues utiles pour le traitement de maladies cardio-vasculaires
JP2007297330A (ja) * 2006-04-28 2007-11-15 Daiso Co Ltd ２−メチルグリシジル誘導体の製造法
JP2007297321A (ja) * 2006-04-28 2007-11-15 Daiso Co Ltd アリール２−メチルグリシジルエーテル類の製造法
US9604930B2 (en) 2012-12-21 2017-03-28 Epizyme, Inc. Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof
US10118918B2 (en) 2012-12-21 2018-11-06 Epizyme, Inc. PRMT5 inhibitors and uses thereof
US9365555B2 (en) 2012-12-21 2016-06-14 Epizyme, Inc. PRMT5 inhibitors and uses thereof
US9908887B2 (en) 2012-12-21 2018-03-06 Epizyme, Inc. PRMT5 inhibitors and uses thereof
JP2016505002A (ja) 2012-12-21 2016-02-18 エピザイム，インコーポレイティド ジヒドロイソキノリンまたはテトラヒドロイソキノリンを含有するｐｒｍｔ５阻害剤およびその使用
WO2015200680A2 (fr) * 2014-06-25 2015-12-30 Epizyme, Inc. Inhibiteurs de prmt5 et leurs utilisations
AU2015301196A1 (en) 2014-08-04 2017-01-12 Epizyme, Inc. PRMT5 inhibitors and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728651A (en) * 1985-10-24 1988-03-01 Hoechst-Roussel Pharmaceuticals Inc. Antihypertensive thieno-isoxazoles and -pyrazoles
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
HUP9603001A3 (en) * 1996-10-30 1999-07-28 Richter Gedeon Vegyeszet Heterocycle compounds comprising nitrogen, process for producing them and pharmaceutical compositions containing the same
PT1054885E (pt) * 1998-02-09 2007-10-03 Duphar Int Res Derivativos de benzisoxazole tendo uma actividade d4-antagonista

Also Published As

Publication number Publication date
AU7577400A (en) 2001-04-17
ES2209995T3 (es) 2004-07-01
WO2001019833A1 (fr) 2001-03-22
CZ2002897A3 (cs) 2002-07-17
DE60006699T2 (de) 2004-09-30
KR20020027647A (ko) 2002-04-13
HRP20020220A2 (en) 2004-02-29
EP1216250A1 (fr) 2002-06-26
AR032134A1 (es) 2003-10-29
EE200200135A (et) 2003-04-15
DK1216250T3 (da) 2004-02-23
SK3512002A3 (en) 2003-03-04
EA200200355A1 (ru) 2002-10-31
HUP0203526A3 (en) 2004-12-28
CA2383340C (fr) 2010-06-15
MXPA02002695A (es) 2002-07-30
DE60006699D1 (en) 2003-12-24
PT1216250E (pt) 2004-04-30
BR0014515A (pt) 2002-06-25
TW530060B (en) 2003-05-01
IL148623A0 (en) 2002-09-12
JP2003509432A (ja) 2003-03-11
EP1216250B1 (fr) 2003-11-19
ZA200201762B (en) 2003-08-27
CA2383340A1 (fr) 2001-03-22
ATE254621T1 (de) 2003-12-15
JP4847662B2 (ja) 2011-12-28
PL354515A1 (en) 2004-01-26
NO20021251D0 (no) 2002-03-13
HUP0203526A2 (hu) 2003-01-28
CY1101692T1 (el) 2010-07-28

Similar Documents

Publication Publication Date Title
WO2008156713A3 (fr) Compositions thérapeutiques anti-cd20 et procédés correspondants
CL2008001960A1 (es) Compuestos derivados de tetrahidropiranocromano, procedimiento de preparacion, composicion farmaceutica, util para inhibir gamma-secretasa, destinados al tratamiento de enfermedades neurodegenetarivas, enfermedad de alzheimer e inhibir el deposito de proteina amiloide.
WO2007014238A8 (fr) Utilisation de dose unique de molecules de liaison specifique au cd20
WO2006073973A3 (fr) Nouveaux dérivés de benzylamine en tant qu'inhibiteurs de cetp
MY150088A (en) Immunosuppressant compounds and compositions
WO2005019179A3 (fr) Processus de preparation de 3-benzazepines
WO2006064453A3 (fr) Agents de ciblage pour une imagerie moleculaire
WO2006102557A3 (fr) Traitement de troubles lies a la degradation de proteines
WO2008070111A3 (fr) Procédés de préparation de (r)-8-chloro-1-méthyl-2,3,4,5-tétrahydro-1h-3-benzazépine et intermédiaires de celle-ci
WO2004009062A3 (fr) Antagonistes du recepteur nmda et leur utilisation pour inhiber l'hyperphosphorylation de la proteine associee aux microtubules tau
GB0621244D0 (en) Methods and compositions for treatment of ion imbalances
WO2007109799A3 (fr) Polymorphes de malate d'eszopiclone
WO2004106322A3 (fr) Polymorphes d'aripiprazole
MXPA02002695A (es) Derivados de propilo tienoisoxazolil- y tienilpirrazolil-fenoxi sustituidos utiles como antagonistas de d4.
WO2010000089A8 (fr) Stat3 et tyk2 en tant que cibles de médicaments pour maladies neurodégénératives
DE60004543D1 (de) Benzisoxazolyl-, pyridoisoxazolyl- und benzthienyl-phenoxy derivate als d4 antagonisten
WO2005054172A3 (fr) Composes derives de jasmonate, compositions pharmaceutiques et methodes d'utilisation associees
WO2005085188A3 (fr) Composes et procedes pour la therapie antitumorale
WO2006042137A3 (fr) Methodes permettant d'identifier des therapeutiques contre la maladie de parkinson
GB0504103D0 (en) Novel method
WO2005092062A3 (fr) Composes destines aux troubles neurodegeneratifs
WO2006016219A3 (fr) Derives d'acides 1-phenyle alcane carboxyliques pour le traitement de maladies neurodegeneratives
WO2001019832A3 (fr) Derives de propyle et d'ethyle non substitues de phenoxy thienoisoxazole utiles comme antagonistes d¿4?
UA87292C2 (ru) Применение сирамезина для лечения злокачественных опухолей
WO2005107748A3 (fr) Methode de traitement tonique a l'aide de derives d'oxyphenbutazone

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application